Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
1992-11-18
pubmed:abstractText
The expression of the pol gene of human immunodeficiency virus type 1 occurs via a ribosomal frameshift between the gag and pol genes. The resulting protein, a Gag-Pol polyprotein, is produced at a level 5 to 10% of that of the Gag protein. The Gag-Pol polyprotein is incorporated into virions and provides viral protease, reverse transcriptase, and integrase, which are essential for infectivity. It is generally believed that the Gag-Pol polyprotein is incorporated into virions via interaction with the Gag protein, although the details of the mechanism are unknown. To further study this problem, we have constructed a human immunodeficiency virus type 1 proviral genome which overexpresses the Gag-Pol polyprotein (Pr160gag-pol). Transfection of this proviral genome (pGPpr-) into COS-1 cells resulted in the expression of full-length Pr160gag-pol polyprotein. Although the majority of the Pr160gag-pol was confined to the cells, low levels of reverse transcriptase activity were detectable in the cell supernatants. The cotransfection of pGPpr- with a second plasmid which expresses only the Pr55gag precursor (pGAG) resulted in a significantly higher level of Pr160gag-pol in the medium of transfected cells. Sedimentation analysis using sucrose density gradients demonstrated that most Pr160gag-pol was found in fractions corresponding to the density of virion particles, indicating that the Pr160gag-pol polyprotein was released in association with a Pr55gag viruslike particle. To further characterize the requirements for the release, a mutation was constructed to express an unmyristylated Pr160gag-pol polyprotein. Coexpression with Pr55gag demonstrated that the unmyristylated Pr160gag-pol was also incorporated into virion particles. Subcellular fractionation experiments revealed that the distributions of the Pr160gag-polmyr- and Pr160gag-pol in the membrane and cytosol were similar under low- or high-ionic-strength conditions. Taken together, these results suggest that myristylation of the Pr160gag-pol polyprotein is not required for the interaction with the Pr55gag necessary for packaging into a viruslike particle.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-1689917, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-1692347, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-1707986, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-1710290, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-1717718, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-1717719, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-1727601, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-1845888, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-1870215, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-1883539, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-2109101, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-2166812, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-2405382, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-2447506, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-2448875, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-2452901, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-2479031, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-2558687, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-2578227, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-2578615, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-2644259, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-2649693, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-2657099, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-2676191, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-271968, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-2785991, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-2788277, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-2825164, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-2981635, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-2982104, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-3006341, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-3031509, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-3040055, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-3060262, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-3262776, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-3290901, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-3489936, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-3493352, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-3881765, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-3882995, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-6199513, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-6200935, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-6441887, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-6589587, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-6959104, http://linkedlifedata.com/resource/pubmed/commentcorrection/1383561-7160476
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0022-538X
pubmed:author
pubmed:issnType
Print
pubmed:volume
66
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
6304-13
pubmed:dateRevised
2010-9-7
pubmed:meshHeading
pubmed-meshheading:1383561-Base Sequence, pubmed-meshheading:1383561-Fusion Proteins, gag-pol, pubmed-meshheading:1383561-Gene Expression Regulation, Viral, pubmed-meshheading:1383561-Gene Products, gag, pubmed-meshheading:1383561-Genome, Viral, pubmed-meshheading:1383561-HIV Protease, pubmed-meshheading:1383561-HIV Reverse Transcriptase, pubmed-meshheading:1383561-HIV-1, pubmed-meshheading:1383561-Molecular Sequence Data, pubmed-meshheading:1383561-Mutagenesis, Site-Directed, pubmed-meshheading:1383561-Myristic Acid, pubmed-meshheading:1383561-Myristic Acids, pubmed-meshheading:1383561-Protein Biosynthesis, pubmed-meshheading:1383561-Protein Precursors, pubmed-meshheading:1383561-Proviruses, pubmed-meshheading:1383561-RNA-Directed DNA Polymerase, pubmed-meshheading:1383561-Reading Frames, pubmed-meshheading:1383561-Transfection, pubmed-meshheading:1383561-Virus Replication
pubmed:year
1992
pubmed:articleTitle
The nonmyristylated Pr160gag-pol polyprotein of human immunodeficiency virus type 1 interacts with Pr55gag and is incorporated into viruslike particles.
More...